XTX Topco’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

XTX Topco’s Portfolio VRPX Stock Details VRPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-516	Closed	-$4.77K	–	3311
2024 Q4	$4.77K	Buy	+516	New	+$6.86K	﹤0.01%	2202
2022 Q1	–	Sell	-42	Closed	-$36K	–	1019
2021 Q4	$36K	Buy	+42	New	+$43.3K	0.02%	596

Other funds holding VRPX

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VWM

Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return

XTX Topco's VRPX Position: Q1 2025 in Review

XTX Topco sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q1 2025, closing a stake of 516 shares — an estimated $4.77K sold.

XTX Topco first reported a position in VRPX in Q4 2021 and held it in 2 quarters. The position peaked at $36K in Q4 2021. 7 funds tracked by Wall St. Rank hold VRPX as of Q1 2025.

XTX Topco reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
XTX Topco sold 516 Virpax Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $4.77K.
XTX Topco first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
XTX Topco's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $36K in Q4 2021.
7 funds tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.